eligibility for clinicaltrials:NCT00004998 [clinicaltrials_resource:d020449ef9becaddc8644d0dc4afd71a]
Safety and Effectiveness of a New Anti-HIV Drug (AG1549) in Combination With Other Anti-HIV Drugs in HIV-Infected Patients [clinicaltrials:NCT00004998]Effectiveness of a New Anti-HIV Drug (AG1549) Plus Viracept (Nelfinavir) Plus Combivir (Zidovudine/Lamivudine) in HIV-Infected Patients [clinicaltrials:NCT00004999]
eligibility [clinicaltrials_vocabulary:eligibility]
eligibility for clinicaltrials:NCT00004998 [clinicaltrials_resource:d020449ef9becaddc8644d0dc4afd71a]
Bio2RDF identifier
d020449ef9becaddc8644d0dc4afd71a
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:d020449ef9becaddc8644d0dc4afd71a
gender [clinicaltrials_vocabulary:gender]
healthy volunteers [clinicaltrials_vocabulary:healthy-volunteers]
minimum age [clinicaltrials_vocabulary:minimum-age]
text [clinicaltrials_vocabulary:text]
Inclusion Criteria
Pa ...... within 28 days of study entry.
identifier
clinicaltrials_resource:d020449ef9becaddc8644d0dc4afd71a
title
eligibility for clinicaltrials:NCT00004998
@en
type
label
eligibility for clinicaltrials ...... 0449ef9becaddc8644d0dc4afd71a]
@en